Valuation CONMED Corporation

Stocks

Market Closed - NYSE Other stock markets 00:00:02 16/06/2026 +04			5-day change	1st Jan Change
34.16 ^USD	-1.75%		-2.84%	-15.86%

06-01	Conmed enters first omnibus amendment and increased facility activation notice on May 27, 2026 - SEC filing	RE
06-01	CONMED Corporation Amends Credit Agreement And Secures USD 450 Million Term Loan Facility	CI

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	4,146	2,702	3,368	2,114	1,257	1,047	-	-
Change	-	-34.83%	24.64%	-37.22%	-40.53%	-16.73%	-	-
Enterprise Value (EV) ¹	4,810	3,728	4,317	2,995	2,051	1,741	1,626	1,499
Change	-	-22.5%	15.81%	-30.62%	-31.52%	-15.14%	-6.61%	-7.8%
P/E Ratio	73.1x	-33.1x	53.7x	16.1x	26.9x	8.74x	7.5x	6.74x
PBR	5.26x	3.57x	4.04x	2.2x	1.1x	0.88x	0.77x	0.68x
PEG	-	0x	-0x	0x	-0.4x	0x	0.5x	0.6x
Capitalization / Revenue	4.1x	2.58x	2.71x	1.62x	0.91x	0.77x	0.73x	0.69x
EV / Revenue	4.76x	3.57x	3.47x	2.29x	1.49x	1.28x	1.13x	0.99x
EV / EBITDA	24.4x	19.8x	18.3x	11.3x	7.44x	6.37x	5.5x	5.41x
EV / EBIT	33.6x	28.4x	24.8x	14.8x	9.5x	8.58x	7.3x	6.08x
EV / FCF	49.6x	322x	40.6x	19.5x	13.6x	8.94x	9.92x	-
FCF Yield	2.01%	0.31%	2.46%	5.14%	7.36%	11.2%	10.1%	-
Dividend per Share ²	0.8	0.8	0.8	0.8	0.8	-	-	-
Rate of return	0.56%	0.9%	0.73%	1.17%	1.97%	-	-	-
EPS ²	1.94	-2.68	2.04	4.25	1.51	3.98	4.635	5.16
Distribution rate	41.2%	-29.9%	39.2%	18.8%	53%	-	-	-
Net sales ¹	1,011	1,045	1,245	1,307	1,375	1,362	1,436	1,514
EBITDA ¹	197.2	188.7	235.4	265.6	275.9	273.2	295.7	277.2
EBIT ¹	143.3	131.3	174.4	202.8	216	203	222.9	246.4
Net income ¹	62.54	-80.58	64.46	132.4	47.06	120.5	140.1	153.6
Net Debt ¹	663.8	1,026	949.6	881.3	794.1	694	579	452.2
Reference price ²	141.76	88.64	109.51	68.44	40.60	34.77	34.77	34.77
Nbr of stocks (in thousands)	29,247	30,482	30,752	30,891	30,968	30,109	-	-
Announcement Date	26/01/22	02/02/23	31/01/24	05/02/25	28/01/26	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
CONMED CORPORATION	8.74x	1.28x	6.37x	-.--%	1.05B
ABBOTT LABORATORIES	22.18x	3.29x	12.35x	2.89%	154B
MEDTRONIC PLC	20.16x	3.48x	12.52x	3.56%	103B
HOYA CORPORATION	33.34x	8.12x	21.24x	1.2%	55.22B
CENCORA, INC.	14.84x	0.18x	11.13x	0.84%	54.8B
BECTON, DICKINSON AND COMPANY	36.44x	2.93x	10.05x	2.63%	40.3B
MEDLINE INC.	35.05x	1.3x	11.46x	0.22%	30.96B
DEXCOM, INC.	30.79x	5.5x	17.51x	-.--%	29.08B
WEST PHARMACEUTICAL SERVICES, INC.	39.05x	6.75x	24.36x	0.27%	23.23B
TERUMO CORPORATION	23.72x	3.03x	12.36x	1.36%	20.25B
Average	26.43x	3.58x	13.93x	1.3%	51.15B
Weighted average by Cap.	25.38x	3.63x	13.80x	2.09%